Pharma firm Anges and Osaka University to begin testing coronavirus vaccine on animals
[TOKYO] Japanese biopharmaceutical firm Anges Inc said on Tuesday it and partner Osaka University had completed development of a prophylactic DNA vaccine against the new coronavirus and that it would begin testing it in animals soon.
Shares of Anges were untraded with a glut of buy orders in early morning.
There are now more than 350,000 cases of coronavirus infections globally and over 15,000 deaths resulting from the disease it causes, called Covid-19.
REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
The only common thing in S-E Asia is that we all eat rice: Cisco’s Asean president
‘How many will survive?’: Bubble fears arise as China’s humanoid robotics face reality check
Green fuels, autonomous ships: How Singapore is future-proofing its shipping industry
Could stablecoins be the future of money?
